CSI Market
Sign In | Register

Inhibikase Therapeutics Inc (IKT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IKT Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Inhibikase Therapeutics Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent31.21
Marketable Securities, Current SH127.81
Cash & Short-term Investments158.00
Deferred Offering Costs DE0.04
Other Current Assets0.93
Prepaid Expense, Current AS2.35
Total Current Assets162.34
Equipment/Property/Plant Net0.00
Prepaid Expense, Noncurrent, Total PR1.00
Other Assets, Noncurrent0.24
Operating Lease Right Of Use Asset-
Total Assets163.59
Liabilities
Accounts Payable, Current AC0.99
Accrued Liabilities, Current AC9.27
Long-term Debt and Capital Lease Obligations, Current DE0.00
Other Liabilities, Current0.00
Total Current Liabilities10.26
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Contingent Consideration Liability-
Total Liabilities10.26
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock331.92
Retained Earnings / Accumulated Deficit-178.65
Accumulated Other Comprehensive Income-0.07
Other Equity-0.07
Common Stockholder's Equity153.33
Total Stockholder's Equity153.33
Liabilities & Stockholder's Equity163.59
4 historic quarters locked

Sign in to unlock the full Inhibikase Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Inhibikase Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: ikt-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-344707

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.